MedTrace Logo

Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.

NCT01800279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-12-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether kinesitherapy techniques and a myofascial therapy protocol are effective in the treatment of temporomandibular joint dysfunction in patients with fibromyalgia syndrome.

Conditions

  • Temporomandibular Joint Dysfunction Syndrome

Interventions

OTHER

Physiotherapy Protocol

Kinesitherapy * Patient: supine position on the stretcher with a loop of 6 cm in the cervical area. * Tongue in the palate for all applied exercises. * Repetitions of each exercise: 8. Cervical traction. Cranium fore flexion 15 °. Open-close mouth dental contactless (10mm). Opening movement with a small resistor (one finger on chin). Flexion of the head, without actually lifting, resisting in the front. Occipital extension. Cranium fore flexion 15 °. Cervical traction. Myofascial Therapy. Induction suboccipital. Compression - decompression of the TMJ (Temporomandibular Joint). Horizontal Induction TMJ. Deep fascia induction in the temporal region. Deep Induction of the masseter fascia. Deep Induction of the external pterygoid. Induction of intraoral pterygoid.

OTHER

Deontology Therapy

For the realization of the splint, the following protocol will be developed at the Faculty of Dentistry of Granada (Spain): * Impression of the maxilla with chromatic alginate "Phase plus" (Zhermack ©, Rovigo, Italy). * Emptying working models in plaster-stone type IV "Elite Rock" (Zhermack ©, Rovigo, Italy). * Deprogramming occlusal splints were made of polyester plates with terephthalic acid of 3 mm thick Clear 120 model (Dentaflux ©, Ripoll, Madrid). We used a molding machine of thermoplastic vacuum plate "The Machine" Dentaflux ©, Ripoll, Madrid.

Sponsors & Collaborators

  • Universidad de Granada

    collaborator OTHER

  • Andaluz Health Service

    collaborator OTHER_GOV

  • Universidad de Almeria

    lead OTHER

Principal Investigators

  • Adelaida M Castro-Sánchez, PhD · Universidad de Almeria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800279 on ClinicalTrials.gov